D
Daniel M. Shindler
Researcher at University of Medicine and Dentistry of New Jersey
Publications - 5
Citations - 213
Daniel M. Shindler is an academic researcher from University of Medicine and Dentistry of New Jersey. The author has contributed to research in topics: Discontinuation & Mortality rate. The author has an hindex of 5, co-authored 5 publications receiving 209 citations.
Papers
More filters
Journal ArticleDOI
Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study
TL;DR: Diabetes mellitus was an independent predictor of mortality by multivariate Cox proportional hazards regression analysis after adjustments were made for gender, race, age, hypertension, left ventricular dysfunction, chronic pulmonary disease, chronic liver disease, and anemia.
Journal ArticleDOI
Persistence of normotension after discontinuation of lifestyle intervention in the Trial of TONE
TL;DR: Some benefits of structured dietary intervention appears to persist long term in a significant number of patients after discontinuation of the intervention.
Journal ArticleDOI
Traumatic tricuspid regurgitation with cyanosis: Diagnosis by transesophageal echocardiography
TL;DR: This case report demonstrates the utility of transesophageal echocardiography in the rapid diagnosis of cardiac injury from blunt thoracic trauma by identifying a flail tricuspid valve leaflet and regurgitation in a patient with jugular venous distention and hemodynamic instability.
Journal ArticleDOI
Non-drug therapy for hypertension : Do effects on weight and sodium intake persist after discontinuation of intervention?
Journal ArticleDOI
Frequency of ventricular ectopic activity in isolated systolic systemic hypertension.
John B. Kostis,Clifton R. Lacy,Daniel M. Shindler,Nemat O. Borhani,W. Dallas Hall,Alan C. Wilson,Susan D. Krieger,Sandra Chelton +7 more
TL;DR: 24-hour ambulatory electrocardiography was performed in 238 patients with isolated systolic hypertension who participated in the Systolic Hypertension in the Elderly Program (SHEP), and in a group of 100 age- and sex-matched normotensive control subjects.